Atriva takes MEK inhibitor into phase 2 for COVID-19
Atriva Therapeutics is starting a phase 2 trial of its MEK inhibitor ATR-002 in patients with coronavirus infections, saying the drug could help prevent patients ...
Tag: ayurvedic
Mathematical modeling the emergence and spread of new pathogens: Insight for SARS-CoV-2 and other similar viruses
Knowing if and how rapidly an emerging pathogen will spread through a population enables public health officials to make well-informed decisions to protect the public. ...
How to successfully transition patient solutions providers
Switching patient solutions providers, also known as hub providers, is a big decision for any pharmaceutical manufacturer or life sciences organization. The transition can be ...
Trump’s boasting overshadows supply deal for COVID-19 drugs
President Trump’s big agreement with a new US drugmaker to supply drugs for COVID-19 has been overshadowed by his admission he is taking hydroxychloroquine as ...
Hydroxychloroquine and the Coronavirus: Connecting the Dots Through the Biology Knowledge Graph
It would be hard to miss the current interest in finding effective treatment for COVID-19. In this regard, the combination of hydroxychloroquine (HCQ) with azithromycin ...
2020 Biopharma Cold Chain Sourcebook forecasts a $17.2-billion logistics market
The 11th edition of the Biopharma Cold Chain Sourcebook has been published by Pharmaceutical Commerce. The annual edition forecasts an overall market for cold chain ...
NICE backs NHS funding for Roche’s Kadcyla in early breast cancer use
NICE has published final draft guidance recommending regular NHS funding for Roche’s Kadcyla (trastuzumab emtansine) in its newer use, for certain people with HER2-positive early breast cancer who are at ...
Increase visibility of your COVID-19 clinical findings with SSRN
Quickly communicating pertinent clinical information, such as research regarding patient treatments, is critical during public health crises like the ongoing novel coronavirus disease 2019 (COVID-19) ...
Hospital pharmacy survey finds a lack of visibility to internal inventories
Automation exists in most hospital pharmacies, but there are crucial gaps and onerous workarounds. “Medication intelligence” would be the preferred approach, according to an annual ...
Shares in Vertex jump on overnight success of CF triple therapy
Shares in US pharma Vertex were up sharply in premarket trading after its newly-launched cystic fibrosis triple therapy attained blockbuster status almost overnight, leading to a surprise upgrade to ...